The proportion of tumor cells expressing TGF-β1 rose with the advancing stage: high TGF-β1 was found in 47.8% of non-invasive tumors, 73.6% of early invasive, and 77.3% of muscle-invasive carcinoma (Table 2). The gene discussed is TGFB1; the disease is neoplasm.